首页> 美国卫生研究院文献>Journal of Thoracic Disease >Midterm results of treat and repair for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension
【2h】

Midterm results of treat and repair for adults with non-restrictive ventricular septal defect and severe pulmonary hypertension

机译:成人非限制性室间隔缺损和严重肺动脉高压的治疗和修复中期结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundA non-restrictive ventricular septal defect (VSD) can cause intracardiac left to right shunt, which leads to increased pulmonary vascular resistance (PVR) and pulmonary hypertension causes bi-directional or even right-left shunt, namely the Eisenmenger’s syndrome. For patients with non-restrictive VSD with severe pulmonary hypertension at stage of near or to be Eisenmenger’s syndrome, traditional VSD repair carries high mortality and poor prognosis. Recently, targeted drug therapy was used to decrease pulmonary circulation resistance in these patients before they receive defect repair surgery, namely “treat and repair” strategy, however, there is few reports about the midterm result of this strategy in adults with non-restrictive VSD with severe pulmonary hypertension at stage of near or to be Eisenmenger’s syndrome.
机译:背景非限制性室间隔缺损(VSD)会导致心内从左向右分流,从而导致肺血管阻力(PVR)增加,并且肺动脉高压会导致双向甚至右向左分流,即艾森曼格综合症。对于患有非限制性VSD且在接近或即将成为艾森曼格综合症的阶段患有严重肺动脉高压的患者,传统的VSD修复死亡率高且预后不良。最近,在这些患者接受缺损修复手术之前,即“治疗和修复”策略,已采用靶向药物治疗来降低其肺循环阻力,但是,关于非限制性VSD成人该策略的中期结果的报道很少。在接近或成为艾森曼格综合征的阶段患有严重的肺动脉高压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号